Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) Prior to Autologous Hematopoietic Stem Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Final Results from a Prospective Multicenter Study

Rémy Duléry, MD, Laure Lebras, MD, Sylvain Choquet, MD, Roberta Di Blasi, Ahmad Kanj AL Jijakli, Laurence Heuberger, Eolia Brissot, MD PhD, Giorgia Battipaglia, MD, Florent Malard, MD PhD, Clemence Mediavilla, MD, Anne Vekhoff, MD, Paul Coppo, MD PhD, Tounes Ledraa, MD, Zora Marjanovic, Elise Corre, MD, Simona Lapusan, MD, Malek Aoudjhane, MD, Ramdane Belhocine, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 786.

https://doi.org/10.1182/blood-2019-130651

Published: 2019

Journal Articles

Prognostic Value of Immunohistochemical Markers in Stage III/IV Classical Hodgkin Lymphoma Treated Frontline in the Lysa EORTC 20012 Randomized Protocol

Danielle Canioni, MD, Pauline Brice, MD, Serge Bologna, MD, Laurent Voillat, MD, Jean Gabarre, MD, Olivier Casasnovas, MD, Alain Devidas, MD, Bertrand Coiffier, MD PhD, Malek Aoudjhane, MD, Bruno Audhuy, MD, Marc Andre, MD, Catherine Fortpied, MD, Patrice Carde, MD PhD, Nicolas Mounier, MD, Josette Briere, MD

Blood (2018) 132 (Supplement 1): 4132.

https://doi.org/10.1182/blood-2018-99-118039

Published: 2018

Journal Articles

Texture Analysis on Computed Tomography Predicts the Outcome of Patients with Hodgkin Lymphoma

Remy Dulery, MD, Anthony Dohan, MD, Maxime Barat, Mor Seny Gueye, Catherine Phan, MD, Zora Marjanovic, MD, Malek Aoudjhane, MD, Elise Corre, MD, Marie-Paule Lemonnier, MD, Anne Vekhoff, MD, Laurent Garderet, MD PhD, Ollivier Legrand, MD PhD, Paul Coppo, MD PhD, Philippe Soyer, MD PhD, Caroline Reinhold, MD, Lionel Arrivé, MD PhD, Benoit Gallix, MD PhD, Mohamad Mohty, MD PhD

Blood (2016) 128 (22): 1832.

https://doi.org/10.1182/blood.V128.22.1832.1832

Published: 2016

Journal Articles

Epoetin Beta (Neorecormon®) Treatment for Anemia of Patients with Non-Myeloid Hematological Malignancy under Chemotherapy: Results of a Large Prospective Cohort Study.

Corinne Haïoun, Norbert Ifrah, Philippe Casassus, Bruno Audhuy, Malek Aoudjhane, Jamile Frayfer, Stephanie Rouanet, Pascal Bleuzen, Arash Jenabian, Thierry Facon

Blood (2007) 110 (11): 3777.

https://doi.org/10.1182/blood.V110.11.3777.3777

Published: 2007

Journal Articles

Comparative Outcome of Reduced Intensity and Myeloablative Preparative Regimen in HLA Identical Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years of Age with Acute Myeloblastic Leukaemia: A Retrospective Survey from the Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT).

Malek Aoudjhane, MD, Norbert-Claude Gorin, MD, PhD, Myriam Labopin, MD, Avichai Shimoni, MD, Dietger Niederwieser, MD, Arnon Nagler, MD, Vanderson Rocha, MD

Blood (2005) 106 (11): 1139.

https://doi.org/10.1182/blood.V106.11.1139.1139

Published: 2005

NARROW

TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) Prior to Autologous Hematopoietic Stem Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Final Results from a Prospective Multicenter Study

Prognostic Value of Immunohistochemical Markers in Stage III/IV Classical Hodgkin Lymphoma Treated Frontline in the Lysa EORTC 20012 Randomized Protocol

Texture Analysis on Computed Tomography Predicts the Outcome of Patients with Hodgkin Lymphoma

Epoetin Beta (Neorecormon®) Treatment for Anemia of Patients with Non-Myeloid Hematological Malignancy under Chemotherapy: Results of a Large Prospective Cohort Study.

Email alerts

ASH Publications

American Society of Hematology

TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) Prior to Autologous Hematopoietic Stem Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Final Results from a Prospective Multicenter Study

Prognostic Value of Immunohistochemical Markers in Stage III/IV Classical Hodgkin Lymphoma Treated Frontline in the Lysa EORTC 20012 Randomized Protocol

Texture Analysis on Computed Tomography Predicts the Outcome of Patients with Hodgkin Lymphoma

Epoetin Beta (Neorecormon®) Treatment for Anemia of Patients with Non-Myeloid Hematological Malignancy under Chemotherapy: Results of a Large Prospective Cohort Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only